Royalty Pharma plc is a publicly traded buyer of biopharmaceutical royalties and a funder of innovation in the life sciences sector.
Founded in 1996 and headquartered in New York, the company holds royalty interests in numerous marketed therapies and development-stage product candidates across areas including oncology, rare diseases, and immunology.
It is listed on Nasdaq under the ticker RPRX and has deployed substantial capital to acquire royalties since inception.
Recent activities include royalty acquisitions, R&D co-funding agreements, and the planned acquisition of its external manager.
Official website: royaltypharma.com
To provide comprehensive coverage, we aggregate data and news under the name Royalty Pharma, encompassing the following company names, divisions, and related entities:
RPRX.
This list encompasses current and former names, alternate names, and key divisions associated with Royalty Pharma, ensuring you can easily find all relevant information under a single, unified profile.
